Navigation Links
Tris Pharma Hires President for Generic Pharmaceuticals Business
Date:6/20/2013

MONMOUTH JUNCTION, N.J., June 20, 2013 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that it has named Janet Penner as President of its new generic pharmaceuticals business.   

Tris' generic pharmaceuticals business, with its own distinct sales, marketing and distribution, will be responsible for commercializing Tris' Abbreviated New Drug Applications (ANDAs) while leveraging Tris' considerable manufacturing capabilities. Tris currently has 13 FDA-approved ANDA products, including several 'first-to-market' generics. All of Tris' generic products are manufactured in its FDA-inspected, state-of-the art 130,000-square-foot facility in New Jersey.  

"Tris' generics initiative is a natural evolution of the overall strategic vision at Tris; bringing technologically-challenging, high-quality products to the marketplace," said Ketan Mehta, President and CEO of Tris Pharma.

Janet comes to Tris with a wealth of expertise in the commercialization of generic products. She brings nearly 15 years of experience in leadership roles within the generic pharmaceuticals industry, including AmerisourceBergen, where she was responsible for the purchasing of generic pharmaceuticals. Most recently, Janet headed sales & marketing at CorePharma. Janet has also held various positions of growing responsibility at General Electric and PepsiCo, and holds an MBA.

"Tris' unique technology for liquid sustained-release products, along with the continued expansion of its strategic pipeline of both liquid and solid oral dosage ANDA development projects, has me truly excited to spearhead the generic pharmaceuticals business at Tris," said Ms. Penner.

About Tris Pharma
Tris Pharma is a specialty pharmaceutical company focused on the research and develo
'/>"/>

SOURCE Tris Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... -- Research and Markets  has announced the addition ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... monitor, and assess medical conditions, diseases, or infections usually ... earlier and more targeted treatment. These tests are minimally ... This kind of diagnostics provides early detection of diseases ...
(Date:7/22/2014)... , July 22, 2014 BiologicTx ® ... first 3-way Kidney Paired Donation transplant exchange ... procedures happened on July 9 at the Miami Transplant ... Miami, Fla. Kidney Paired ... are not compatible for kidney transplant with one another ...
(Date:7/22/2014)... , July 22, 2014  A central ... a SynCardia temporary Total Artificial Heart ... Strong Memorial Hospital with the Freedom® portable driver ... Fontana, a 64-year-old retiree from a Syracuse ... He managed the condition with medications, an implantable ...
Breaking Medicine Technology:Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 2Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 3BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3
... Calif., Feb. 24, 2011 Codexis, Inc. (Nasdaq: ... promoted to Chief Technology Officer and Senior Vice President, Process ... report to Alan Shaw, Ph.D., President and Chief Executive Officer. ... a 25-year career with DuPont. He served as Vice President, ...
... Par Pharmaceutical Companies, Inc. (NYSE: PRX ) ... ended December 31, 2010. For the fourth quarter ... $227 million and income from continuing operations of $17.6 million, ... million charge related to the settlement of litigation and changes ...
Cached Medicine Technology:Codexis Names David Anton CTO & SVP, Process Development & Manufacturing 2Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 2Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 3Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 4Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 5Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 6Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 7Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 8Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 9Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 10
(Date:7/22/2014)... By Steven Reinberg ... -- Simple blood tests may one day help predict survival ... lateral sclerosis (ALS), also called Lou Gehrig,s disease, Italian researchers ... yield clues to how fast ALS is progressing are called ... kidney and liver health, according to the U.S. National Library ...
(Date:7/22/2014)... (Boston)-- Researchers from Boston University School of Medicine ... that participants who received care through BMC,s Violence ... physical, mental, emotional and social needs of violently ... injuries and experienced life changing behaviors through connections ... feel trust and hope. These findings are reported ...
(Date:7/22/2014)... European Bio stimulants Market report defines and segments the ... of revenue. The bio stimulants market in Europe is ... to $940.6 million by 2018, at a CAGR of ... TOC of the Europe Bio stimulants Market report, to ... http://www.micromarketmonitor.com/market/europe-bio-stimulants-1315565884.html , Agriculture contributes to 10% of ...
(Date:7/22/2014)... In a special day of pampering ... School of Beauty joined forces with The Discovery ... a free “Make-over Day.” In a win-win event, Marinello ... the community, and The Discovery House clients had a ... some first-hand experience about career possibilities. , “The ...
(Date:7/22/2014)... 22, 2014 Expert Publishing ... Services , announces the launch of PoisonEXPERT™ ... and safety professionals employed by organizations that use ... to manage the impact of chemicals on their ... to relevant chemical-specific information and medical protocols that ...
Breaking Medicine News(10 mins):Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 2Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 3Health News:Clients of BMC's violence interventional advocacy program find experience supportive 2Health News:Clients of BMC's violence interventional advocacy program find experience supportive 3Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 5Health News:The Discovery House 'Make-over Day' Adds Pampering To Recovery 2Health News:The Discovery House 'Make-over Day' Adds Pampering To Recovery 3Health News:PoisonEXPERT™ from ExPub Now Available 2Health News:PoisonEXPERT™ from ExPub Now Available 3
... turning their backs on tanning amid growing concerns over skin ... survey shows that teenagers are resisting the urge to tan ... 5,073 Australian adults and 699 Australian teenagers aged 12 to ... that 68 % of those aged 12-17 said they had ...
... University have found a new model that shows how ... in the presence of microenvironment of tumor cells. // ... skin cell to malignant cell is understood with the ... offer new insights into the influence of the tumor ...
... the developing fetus, a womb confers safety and security to ... a womb is even necessary for normal brain development. // ... found to have a poor brain development when compared to ... done regarding brain development of babies born around 26 weeks ...
... bottle-feeding may impose an increased risk of iron deficiency ... American children) according to // a new study by ... Wisconsin. , ,"This is the first study that ... prolonged bottle-feeding and iron deficiency, among a nationally representative ...
... in the UK has revealed that smokers are unconcerned with ... particular they seemed to be aware of the damage // ... lip and even the teeth, but were strangely reluctant to ... oral and maxillofacial surgeons, who are launching a massive awareness ...
... across the walls of a patient's room have been ... hypertension and rheumatic complaints, a study says.//,A study group ... kept in medicated rooms were cured in shorter less ... study involved 36 patients, of whom 19 were kept ...
Cached Medicine News:Health News:Aussie teens applauded for declining sun tan 2Health News:New Model for understanding Tumor Metastasis 2Health News:Brain development compromised in premature babies 2Health News:Iron deficiency found in children with prolonged bottle feeding 2Health News:Now medicated coir to cure ailments 2
Agarose L03 is recommended for separations of DNA fragments = 1,000 bp....
... Anion traces: chloride (Cl) ≤ 5000 mg/kg sulfate (SO ... 50 mg/kg Cd ≤ 5 mg/kg Co ≤ 5 ... Fe ≤ 10 mg/kg K ≤ 50 mg/kg Mg ... 2000 mg/kg Ni ≤ 5 mg/kg Pb ≤ 5 ...
... ≤ 5000 mg/kg sulfate (SO 4 ) ≤ 5000 ... 5 mg/kg Co ≤ 5 mg/kg Cr ≤ 5 ... K ≤ 50 mg/kg Mg ≤ 5 mg/kg Mn ... 5 mg/kg Pb ≤ 5 mg/kg Zn ≤ 5 ...
... flexible gels for separation of ... of wide range and standard ... mg/mL, clear, faintly yellow, hot ... MP: 90 °C (1% in ...
Medicine Products: